Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη της αγγειογένεσης στην αληθή πολυκυτταραιμία

Abstract

dc:description

The role of angiogenesis is critical for tumor and haematopoietic malignancies progression and is under investigation for myeloproliferative diseases. Increased angiogenic activity has been demonstrated in myelofibrosis with myeloid metaplasia, chronic myeloid leukemia, and essential thrombocythemia. Few are reported on angiogenesis in Polycythaemia Vera (PV) and the significance of angiogenic stimulators as Vascular Endothelial Growth Factor (VEGF), basic Fibroblast Growth Factor (b FGF) Angiogenin (Ang), Metalloproteinase-9 and the microvessel density (MVD) in trephine biopsies of polycythaemic patients. Therefore, we report our observations in patients with PV concerning the serum levels of VEGF and b FGF, Αngiogenin and Metalloproteinase-9, as well as the microvessel density in bone marrow samples immunostained with anti- CD₃₄ monoclonal antibody. A total of 38 patients with PV (22 males and 16 females) with a mean age of 56,1±2,5 (m ± SΕΜ) years (range 21-81) were included. Τwenty two patients were managed with phlebotomy, four received hydroxyurea, eight were managed with hydroxyurea and phlebotomy and one was treated with interferon and three patients did not get any treatment. Three had clinically detected spleen enlargement and fiver had experienced a thrombotic complication. The control group consisted of 22 healthy subjects (mean age 55,3 ± 1,3 years). The age difference between the two groups was not statistically significant (p=0,82). Serum levels of VEGF, bFGF, Ang and ΜΜP-9 were measured by commercial quantitatives sandwich enzyme immunoassays. In twenty four of them we estimated the MVD in bone marrow samples immunostained with anti-CD₃₄ monoclonal antibody by counting the number of vessels per 400x high power field (HPF) using light microscopy. Serum VEGF levels in PV were found to be significantly higher than in healthy individuals (510,6 ± 87,8 vs 182,7 ± 27,2, pg/ml respectively, p=0,032). We found no correlation between VEGF and haemoglobin, platelet or leukocyte counts in the patient group. Different therapeutic regimens had no influence on VEGF levels. However, in the control group, we observed a positive correlation between VEGF levels and platelet counts (r=0,48, p=0,038). Platelet counts did not differ between patients and healthy subjects. We also evaluated b FGF levels in the two groups. We found no differences in serum b FGF concentrations between patients and controls. In the patient group we found no correlation between b FGF levels and platelet count, Hb, WBC count, age and therapeutic regimen. On the contrary we found a very interesting positive correlation between b FGF and VEGF levels only in the group of PV patients (r=0,42, p=0,009). Serum Angiogenin levels were found to be significantly higher than in healthy individuals 432,2 ± 24 pg/ml and 366,1 ± 31,4 pg/ml respectively, (p=0,036). Interestingly a negative correlation was found between serum Angiogenin levels and the microvessel density of the bone marrow. We also found that patients with a thrombotic complication had lower angiogenin levels in comparison to patients without such a complication (279,6 ± 4,7 vs 457,7 ± 36,5, p=0,019). We found no differences in serum Metalloproteinase-9 concentrations between patients and controls and we found a positive correlation between VEGF levels and MMP-9 levels (r=0,36, p=0,03) in patients group. The microvessel density was found significantly higher (4,2 ± 0,4 vessels per HPF) in comparison to control groups that were consisted by 10 normal individuals (1,6 ± 0,2 vessels per HPF) and 12 patients with other myeloproliferative disorder (9,0 ± 1,5 vessels per HPF). We divided the group of patients in two subgroups according to the grade of fibrosis (grade 0-1 and grade 1-2) of their bone marrows. In the first subgroup we found 3,4 ± 0,9 vessels per HPF while in the second subgroup we found 5,3 ± 2,1 vessels per HPF. The difference among the two groups is statistically significant (p=0,005) and we found a positive correlation between MVD and reticulin fibrosis grade in patients with PV (r=0,59, p=0,0025). We also measured the angiogenetic factors that are implicated in fibroblast proliferation, bFGF (basic Fibroblast Growth Factor) and VEGF (Vascular Endothelial Growth Factor), in the sera of the two groups of PV patents. We found no statistically significant difference among the two subgroups (p= 0,42 and p=0,84) respectively. Our study showed an increased angiogenic activity in patients with polycythaemia vera independently of the therapeutic approach. The exact contribution of the angiogenic factors that we have measured in the pathophysiology of PV and their prognostic significance as disease activity markers deserve further research.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Theodoridou, Stamatia
  • Θεοδωρίδου, Σταματία

Subjects

dc:subject × 17

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19524

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Theodoridou, Stamatia; Θεοδωρίδου, Σταματία. Μελέτη της αγγειογένεσης στην αληθή πολυκυτταραιμία. Aristotle University Of Thessaloniki (AUTH), 2007. http://hdl.handle.net/10442/hedi/19524